760 related articles for article (PubMed ID: 25907157)
1. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
[TBL] [Abstract][Full Text] [Related]
3. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
Trials; 2014 Jun; 15():217. PubMed ID: 24916319
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.
Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
Trials; 2010 Oct; 11():99. PubMed ID: 20961444
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
[TBL] [Abstract][Full Text] [Related]
8. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
[TBL] [Abstract][Full Text] [Related]
9. Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies.
Tickell A; Byng R; Crane C; Gradinger F; Hayes R; Robson J; Cardy J; Weaver A; Morant N; Kuyken W
BMJ Open; 2020 Feb; 10(2):e033892. PubMed ID: 32075835
[TBL] [Abstract][Full Text] [Related]
10. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
Pahlevan T; Ung C; Segal Z
Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up.
Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z
Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511
[TBL] [Abstract][Full Text] [Related]
12. Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.
Huijbers MJ; Spijker J; Donders AR; van Schaik DJ; van Oppen P; Ruhé HG; Blom MB; Nolen WA; Ormel J; van der Wilt GJ; Kuyken W; Spinhoven P; Speckens AE
BMC Psychiatry; 2012 Aug; 12():125. PubMed ID: 22925198
[TBL] [Abstract][Full Text] [Related]
13. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken W; Byford S; Taylor RS; Watkins E; Holden E; White K; Barrett B; Byng R; Evans A; Mullan E; Teasdale JD
J Consult Clin Psychol; 2008 Dec; 76(6):966-78. PubMed ID: 19045965
[TBL] [Abstract][Full Text] [Related]
14. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
[TBL] [Abstract][Full Text] [Related]
15. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.
Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE
Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
Kuyken W; Warren FC; Taylor RS; Whalley B; Crane C; Bondolfi G; Hayes R; Huijbers M; Ma H; Schweizer S; Segal Z; Speckens A; Teasdale JD; Van Heeringen K; Williams M; Byford S; Byng R; Dalgleish T
JAMA Psychiatry; 2016 Jun; 73(6):565-74. PubMed ID: 27119968
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
[TBL] [Abstract][Full Text] [Related]
19. An open trial of mindfulness-based cognitive therapy for the prevention of perinatal depressive relapse/recurrence.
Dimidjian S; Goodman SH; Felder JN; Gallop R; Brown AP; Beck A
Arch Womens Ment Health; 2015 Feb; 18(1):85-94. PubMed ID: 25298253
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
